⌘K
Loading ticker…
As of 2026-08-24, Actinium Pharmaceuticals, Inc (ATNM) has a 3-month relative strength percentile of 29 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 43. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.6%, relative volume 0.36×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
ATNM is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $914K notional.
Held by 3 ETFs · $1M across latest filings · largest weight 0.01% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $914K | — |
| VXFVanguard Extended Market ETF | 0.00% | $303K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ATNM Jan avg: -1.67% median: -1.01% win: 50% σ: 11.60% n: 4 2022-04-12 → 2026-07-31 | ATNM Feb avg: 10.44% median: 0.43% win: 50% σ: 33.21% n: 4 2022-04-12 → 2026-07-31 | ATNM Mar avg: 3.52% median: -5.14% win: 25% σ: 24.95% n: 4 2022-04-12 → 2026-07-31 | ATNM Apr avg: 2.09% median: -1.66% win: 40% σ: 9.52% n: 5 2022-04-12 → 2026-07-31 | ATNM May avg: 1.46% median: 1.32% win: 60% σ: 8.65% n: 5 2022-04-12 → 2026-07-31 | ATNM Jun avg: -12.80% median: -10.60% win: 0% σ: 5.48% n: 5 2022-04-12 → 2026-07-31 | ATNM Jul avg: -1.24% median: -4.04% win: 40% σ: 11.62% n: 5 2022-04-12 → 2026-07-31 | ATNM Aug avg: -8.76% median: -3.19% win: 50% σ: 48.00% n: 4 2022-04-12 → 2026-07-31 (current) | ATNM Sep avg: -3.04% median: -3.51% win: 25% σ: 6.40% n: 4 2022-04-12 → 2026-07-31 | ATNM Oct avg: 15.71% median: -5.00% win: 25% σ: 45.25% n: 4 2022-04-12 → 2026-07-31 | ATNM Nov avg: -14.92% median: -18.08% win: 0% σ: 7.67% n: 4 2022-04-12 → 2026-07-31 | ATNM Dec avg: -1.71% median: -2.62% win: 25% σ: 9.67% n: 4 2022-04-12 → 2026-07-31 |